Replies to post #132489 on Biotech Values

[genisi]

PLX goes down 13% here on the delay.

[ghmm]

PLX (the distant cousin of PRX :-)):

Did anyone take notice of their recent PR about their manufacturing being successfully inspected by the EU, Brazil and Israel. It seemed a little unusual to PR that. A pessimist may think they are trying to downplay the US approval risk.